Obesity
Not recruitingStudy of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes
Germany- Participants:18–64 years · 65+ years
- Substances:HRS 9531
Rare diseases
Investigational molecules
Locations
Back to Germany18 clinical trials in Falkensee, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 2 Diabetes Mellitus management and glycemic control, evaluating new therapeutic approaches including novel compounds and established treatments.
Multiple trials are investigating both single and combination therapies for improving patient outcomes.
Comprehensive studies addressing atherosclerotic cardiovascular disease and cholesterol management, examining innovative treatments for reducing major adverse cardiovascular events.
Research focuses on comparing effectiveness of different therapeutic approaches for cholesterol control.
Groundbreaking research combining treatments for chronic kidney disease and metabolic conditions, including studies on weight management and obesity-related complications.
Trials evaluate combination therapies targeting multiple health conditions simultaneously.
Tell us about your condition – we search every trial in Europe and connect you with the right site.